Cargando…
Survival of patients with stage IIIC and IIID melanomas with nodal metastases in the light of new therapies
INTRODUCTION: Within stage III melanoma prognosis and outcomes significantly vary. Advances in systemic therapy improved prognosis in metastatic melanoma. Adjuvant therapy in stage III significantly lowered relapses, although the effect on survival is less evident. Analysis of treatment results in s...
Autores principales: | Ziętek, Marcin, Zdzienicki, Marcin, Wierzbicki, Jędrzej, Cybulska-Stopa, Bożena, Krotewicz, Maria, Łobaziewicz, Wojciech, Wysocki, Wojciech M., Kamińska-Winciorek, Grażyna, Turska-d’Amico, Maria, Rutkowski, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837581/ https://www.ncbi.nlm.nih.gov/pubmed/36685997 http://dx.doi.org/10.5114/ada.2022.119971 |
Ejemplares similares
-
The Current Treatment Trends and Survival Patterns in Melanoma Patients with Positive Sentinel Lymph Node Biopsy (SLNB): A Multicenter Nationwide Study
por: Ziętek, Marcin, et al.
Publicado: (2023) -
Characteristics of Giant Nodular Melanomas in Special Locations: a Case Series and Review of the Literature
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2022) -
Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors
por: Kamińska-Winciorek, Grażyna, et al.
Publicado: (2019) -
Treatment of Locally Advanced Merkel Cell Carcinoma—A Multi-Center Study
por: Dudzisz-Sledz, Monika, et al.
Publicado: (2022) -
Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)